Kaplan GG - Search Results

1

Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.

Cholapranee A, Hazlewood GS, Kaplan GG, Peyrin-Biroulet L, Ananthakrishnan AN. Cholapranee A, et al. Among authors: kaplan gg. Aliment Pharmacol Ther. 2017 May;45(10):1291-1302. doi: 10.1111/apt.14030. Epub 2017 Mar 22. Aliment Pharmacol Ther. 2017. PMID: 28326566 Free PMC article. Review.

2

Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis.

Mao EJ, Hazlewood GS, Kaplan GG, Peyrin-Biroulet L, Ananthakrishnan AN. Mao EJ, et al. Among authors: kaplan gg. Aliment Pharmacol Ther. 2017 Jan;45(1):3-13. doi: 10.1111/apt.13847. Epub 2016 Nov 10. Aliment Pharmacol Ther. 2017. PMID: 27862107 Free article. Review.

3

Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infection.

Kassam Z, Cribb Fabersunne C, Smith MB, Alm EJ, Kaplan GG, Nguyen GC, Ananthakrishnan AN. Kassam Z, et al. Among authors: kaplan gg. Aliment Pharmacol Ther. 2016 Mar;43(6):725-33. doi: 10.1111/apt.13546. Epub 2016 Feb 5. Aliment Pharmacol Ther. 2016. PMID: 26849527 Free PMC article.

4

Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus.

Ananthakrishnan AN, Kaplan GG, Bernstein CN, Burke KE, Lochhead PJ, Sasson AN, Agrawal M, Tiong JHT, Steinberg J, Kruis W, Steinwurz F, Ahuja V, Ng SC, Rubin DT, Colombel JF, Gearry R; International Organization for Study of Inflammatory Bowel Diseases. Ananthakrishnan AN, et al. Among authors: kaplan gg. Lancet Gastroenterol Hepatol. 2022 Jul;7(7):666-678. doi: 10.1016/S2468-1253(22)00021-8. Epub 2022 Apr 27. Lancet Gastroenterol Hepatol. 2022. PMID: 35487235 Review.

5

Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting.

Rubin DT, Abreu MT, Rai V, Siegel CA; International Organization for the Study of Inflammatory Bowel Disease. Rubin DT, et al. Gastroenterology. 2020 Jul;159(1):6-13.e6. doi: 10.1053/j.gastro.2020.04.002. Epub 2020 Apr 6. Gastroenterology. 2020. PMID: 32272113 Free PMC article. No abstract available.

6

Systematic review: the short-term and long-term efficacy of adalimumab following discontinuation of infliximab.

Ma C, Panaccione R, Heitman SJ, Devlin SM, Ghosh S, Kaplan GG. Ma C, et al. Among authors: kaplan gg. Aliment Pharmacol Ther. 2009 Nov 15;30(10):977-86. doi: 10.1111/j.1365-2036.2009.04101.x. Epub 2009 Jul 22. Aliment Pharmacol Ther. 2009. PMID: 19681810 Free article. Review.

7

Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn's disease: a cost-effectiveness analysis.

Kaplan GG, Hur C, Korzenik J, Sands BE. Kaplan GG, et al. Aliment Pharmacol Ther. 2007 Dec;26(11-12):1509-20. doi: 10.1111/j.1365-2036.2007.03548.x. Epub 2007 Oct 11. Aliment Pharmacol Ther. 2007. PMID: 17931345 Free article.

8

The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study.

Reich KM, Chang HJ, Rezaie A, Wang H, Goodman KJ, Kaplan GG, Svenson LW, Lees G, Fedorak RN, Kroeker KI. Reich KM, et al. Among authors: kaplan gg. Aliment Pharmacol Ther. 2014 Sep;40(6):629-38. doi: 10.1111/apt.12873. Epub 2014 Jul 13. Aliment Pharmacol Ther. 2014. PMID: 25039715 Free article.

9

Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohort.

Ma C, Fedorak RN, Kaplan GG, Dieleman LA, Devlin SM, Stern N, Kroeker KI, Seow CH, Leung Y, Novak KL, Halloran BP, Huang VW, Wong K, Blustein PK, Ghosh S, Panaccione R. Ma C, et al. Among authors: kaplan gg. Aliment Pharmacol Ther. 2017 May;45(9):1232-1243. doi: 10.1111/apt.14016. Epub 2017 Mar 2. Aliment Pharmacol Ther. 2017. PMID: 28252210

10

Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease.

Moran GW, Lim AW, Bailey JL, Dubeau MF, Leung Y, Devlin SM, Novak K, Kaplan GG, Iacucci M, Seow C, Martin L, Panaccione R, Ghosh S. Moran GW, et al. Among authors: kaplan gg. Aliment Pharmacol Ther. 2013 Nov;38(9):1002-24. doi: 10.1111/apt.12491. Epub 2013 Sep 25. Aliment Pharmacol Ther. 2013. PMID: 24099467 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

405 results

Search Page